GENFIT invests up to $105M for Versantis to Up Liver Game
1 year ago
57
Genfit is spreading its bets in a rare liver disease with the buyout of Versantis, a clinical-stage biotech whose most advanced drug candidate brings a novel approach to treating a liver disease complication that has no FDA-approved therapies. And yes, Genfit already has a drug candidate on track for the treatment of acute-on-chronic liver failure (ACLF). But by acquiring Versantis, it adds another drug that works in a different way and is further along in development for the same disorder.
Loading comments...
-
LIVE
Price of Reason
9 hours agoDisney MASSIVE Layoffs! Star Trek Franchise REBOOT? Gaming "Journalism" COLLAPSE! W/ Dreadroberts
1,293 watching -
3:23:38
Jerry After Dark
12 hours agoJerry After Dark: Warzone ft. Nickmercs
32.7K1 -
DVR
Geeks + Gamers
4 hours agoTuesday Night's Main Event
7.94K3 -
1:57:04
Kim Iversen
4 hours agoWEF’s Klaus Schwab Is Retiring. Who's Next? GOP Bill Gives VA Benefits To IDF Soldiers | Anti-Genocide 2024 Candidate Jill Stein
25.8K88 -
2:21:54
Laura Loomer
4 hours agoEP48: Biden DOJ Authorized FBI Assassination of President Trump as Sham NYC Trial Insanity Continues
35.2K81 -
15:57
Breaking Points
11 hours agoBlinken THREATENS GLOBAL STARVATION In Secret Arab Meeting
23.6K40 -
1:24:20
TheMonicaCrowleyPodcast
10 hours agoThe Monica Crowley Podcast: Liars, Circuses and Bioweapons
20.9K9 -
54:33
LFA TV
18 hours agoPoetic Justice as CNN Forced to Defend Donald Trump | Trumpet Daily 5.21.24 9pm EST
19.5K6 -
53:50
The Late Kick with Josh Pate
6 hours agoLate Kick Live Ep 515: Rashada Sues Napier | Conference Sleepers | Bold Predictions | Nebraska Mood
27.1K3 -
1:02:46
The StoneZONE with Roger Stone
5 hours agoWho Shot Down The President Of Iran? + Zelensky Cancels Elections…AGAIN | The StoneZONE
34.4K41